Approaches to the discovery of pharmacogenomic markers in oncology: 2000–2010–2020

Author： Huang R Stephanie Dolan M Eileen

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.11, Iss.4, 2010-04, pp. : 471-474

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Synergistic Approaches to Clinical Oncology Biomarker Discovery

Current Topics in Medicinal Chemistry, Vol. 5, Iss. 11, 2005-09 ,pp. : 1047-1051

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomic Approaches to Osteoporosis: 2005 Update

Current Pharmacogenomics, Vol. 4, Iss. 4, 2006-01 ,pp. : 271-276

Bentham Science Publishers

Access to resources Recommend Favorite

Lymphoblastoid cell lines in pharmacogenomic discovery and clinical translation

By Wheeler Heather E Dolan M Eileen

Pharmacogenomics, Vol. 13, Iss. 1, 2012-01 ,pp. : 55-70

Future Medicine

Access to resources Recommend Favorite

PET and SPECT Imaging of Tumor Biology: New Approaches Towards Oncology Drug Discovery and Development

Current Computer - Aided Drug Design, Vol. 4, Iss. 1, 2008-03 ,pp. : 46-53

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacogenomic approaches that may guide preeclampsia therapy

By Luizon Marcelo R Sandrim Valeria C

Pharmacogenomics, Vol. 14, Iss. 6, 2013-04 ,pp. : 591-593

Future Medicine

Access to resources Recommend Favorite